The 28th Gail Klein Garlove Lectureship on Nov. 1 is titled “Advancing Precision Medicine Through New Discoveries and Technologies,” and will be presented by Sameek Roychowdhury, M.D., Ph.D., medical director of the cancer genomics laboratory and medical oncologist at The Ohio State University Comprehensive Cancer Center – James. The event is hosted by Norton Healthcare Institute for Education & Development and made possible by a gift to the Norton Healthcare Foundation.
“Dr. Roychowdhury, a recognized leader in the advancing discipline of precision medicine, will discuss the incorporation of multidisciplinary care focused around novel molecular changes in patients’ cancer to tailor specific therapies to the individual,” said Joseph M. Flynn, D.O., MPH, FACP, chief administrative officer, Norton Medical Group, and physician-in-chief, Norton Cancer Institute. “This is the future of cancer care, and he will explain how best to combine genomics, computer science, novel diagnostics, biology and clinical trials to deliver precision cancer medicine to patients.”
The lecture Wednesday is from 5:30 to 7:30 p.m. at the Olmsted, 3701 Frankfort Ave., in Louisville. The free lecture is open to the community.
Physicians
Norton Healthcare designates this live educational activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME Activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurses
Norton Healthcare Institute for Education & Development is approved with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This continuing professional development activity has been approved for 1.5 contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.
To register
Register now at this link or call (502) 629-1234, option 4.
Learning objectives:
- Describe the practice implications of microsatellite instability and emerging biomarkers for immunotherapy.
2. Analyze the practice implications of genomic alterations in fibroblast growth factor receptor (FGFR) genes.
3. Discuss the implications of telehealth in clinical trials.
About the speaker
Dr. Roychowdhury is a medical oncologist and associate professor of medical oncology. He earned his medical degree and a doctorate in immunology from The Ohio State University, Columbus. Dr. Roychowdhury leads a multidisciplinary team that combines expertise in genomics, computer science, novel diagnostics, biology and clinical trials to deliver precision cancer medicine to patients. He also serves as medical director of a clinical-grade cancer genomics lab and leads precision medicine trials called basket studies that focus on genetic markers rather than the type of cancer. The team’s research has been funded by the National Cancer Institute, the American Cancer Society, the Prostate Cancer Foundation and the American Lung Association.
About the Gail Klein Garlove Lectureship series
The series is sponsored in honor of Gail Klein Garlove by her children, Matt Lee Garlove Jr., Robin Garlove Fine and Lee Klein Garlove. Mrs. Garlove was born Oct. 28, 1939, and passed away from cancer on July 14, 1994. During her life of dedicated service to the community, she volunteered at Kentucky Country Day School, the Louisville Free Public Library’s “Talking Book” program and the Mormon Home for Retirees. She also worked as an assistant librarian at the Louisville Collegiate School.